ORAMED PHARMACEUTICALS INC. Stock Issued During Period, Value, Purchase of Assets
ORAMED PHARMACEUTICALS INC. (ORMP) reported Stock Issued During Period, Value, Purchase of Assets of $434.88 thousand for the 101-month period ending 2010-08-31, per its 10-Q filed 2012-07-12.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets · last filed 2014-04-10
- 2010-08-31: Stock Issued During Period, Value, Purchase of Assets 101 month $434.88K.
- 2007-08-31: Stock Issued During Period, Value, Purchase of Assets 65 month $434.88K.
| Period end | Stock Issued During Period, Value, Purchase of Assets 65 month | Stock Issued During Period, Value, Purchase of Assets 101 month |
|---|---|---|
| 2010-08-31 | $434.88K 10-Q · filed 2012-07-12 | |
| 2007-08-31 | $434.88K 10-Q · filed 2014-04-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |